Oculis Holding AG business relationships
Companies named in Oculis Holding AG’s 20-F filed 2026-03-04, and public companies whose annual reports name Oculis Holding AG. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 61 / 100 Top 1% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Oculis Holding AG’s annual report 2
“In addition, as of December 31, 2025, we exclusively licensed from Novartis under the Novartis Agreement, in the licensed field as defined in the Novartis Agreement, one patent family directed on a biomarker for patient selection, that consists of one issued U.S. patent and one issued Japanese paten...” SEC filing
“License Agreement by and among Alcon Research, LTD., and Oculis, dated December 19, 2018” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.